Concepedia

Gregory Ferenchak

GF

4

Publications

498

Citations

4

H-Index

2013

Active since

Affiliations

The Ohio State University(Current)

Cancer Genetics (United States)

Université de Montréal

Imperial College London

Hôpital Maisonneuve-Rosemont

Gregory Ferenchak is an author at The Ohio State University specializing in cell biology, engineering, and radiation oncology.

Top concepts

Publications per year

2013–2015

4

Publications

4

PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells

Paolo Neviani, Jason G. Harb, Joshua J. Oaks et al. · Journal of Clinical Investigation · 2013 · 215 citations · Full text

Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias

Christopher J. Walker, Joshua J. Oaks, Ramasamy Santhanam et al. · Blood · 2013 · 145 citations · Full text

Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia

Adrienne M. Dorrance, Paolo Neviani, Gregory Ferenchak et al. · Leukemia · 2015 · 120 citations · Full text

, , +9

Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target

Jason G. Harb, Paolo Neviani, Brenda Chyla et al. · Leukemia · 2013 · 18 citations

, , +11

Rows per page

1–4 of 4